TF
BMY icon

TIAA FSB’s Bristol-Myers Squibb BMY Stock Holding History

TIAA FSB’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$8.45M Buy
132,199
+315
+0.2% +$21.1K 0.03% 180
2023
Q1 		$9.14M Sell
131,884
-6,579
-5% -$464K 0.03% 176
2022
Q4 		$9.96M Sell
138,463
-7,337
-5% -$553K 0.04% 163
2022
Q3 		$10.4M Sell
145,800
-365
-0.2% -$26.5K 0.04% 155
2022
Q2 		$11.3M Sell
146,165
-9,108
-6% -$694K 0.04% 150
2022
Q1 		$11.3M Sell
155,273
-6,823
-4% -$458K 0.04% 155
2021
Q4 		$10.1M Sell
162,096
-15,033
-8% -$882K 0.03% 165
2021
Q3 		$10.5M Buy
177,129
+1,427
+0.8% +$94K 0.04% 161
2021
Q2 		$11.7M Sell
175,702
-121,586
-41% -$7.93M 0.04% 153
2021
Q1 		$18.8M Sell
297,288
-217,800
-42% -$13.6M 0.07% 109
2020
Q4 		$32M Buy
515,088
+1,843
+0.4% +$113K 0.12% 73
2020
Q3 		$30.9M Buy
513,245
+25,582
+5% +$1.54M 0.14% 72
2020
Q2 		$28.7M Buy
487,663
+93,987
+24% +$5.62M 0.14% 71
2020
Q1 		$21.9M Buy
393,676
+27,458
+7% +$1.68M 0.13% 73
2019
Q4 		$23.5M Buy
366,218
+114,574
+46% +$6.56M 0.11% 78
2019
Q3 		$12.8M Buy
251,644
+139,142
+124% +$6.54M 0.07% 104
2019
Q2 		$5.1M Sell
112,502
-9,548
-8% -$445K 0.03% 165
2019
Q1 		$5.82M Buy
122,050
+3,134
+3% +$156K 0.05% 148
2018
Q4 		$6.18M Buy
118,916
+350
+0.3% +$18.8K 0.04% 141
2018
Q3 		$7.36M Sell
118,566
-415
-0.3% -$24.6K 0.04% 133
2018
Q2 		$6.58M Sell
118,981
-2,166
-2% -$117K 0.04% 135
2018
Q1 		$7.66M Sell
121,147
-5,432
-4% -$349K 0.04% 124
2017
Q4 		$7.76M Buy
126,579
+12,207
+11% +$764K 0.04% 128
2017
Q3 		$7.29M Buy
114,372
+841
+0.7% +$49.1K 0.05% 128
2017
Q2 		$6.33M Buy
+113,531
New +$6.18M 0.04% 136

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

TIAA FSB's BMY Position: Q2 2023 in Review

TIAA FSB increased its Bristol-Myers Squibb (BMY) stake by 0.24% in Q2 2023, buying an estimated $21.1K and bringing the position to 132,199 shares worth $8.45M. The position accounts for 0.03% of the portfolio, ranked #180.

TIAA FSB first reported a position in BMY in Q2 2017 and has held it in 25 quarters since. The position peaked at $32M in Q4 2020. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

  • TIAA FSB held 132,199 shares of Bristol-Myers Squibb worth $8.45M as of Q2 2023.
  • TIAA FSB bought 315 Bristol-Myers Squibb shares in Q2 2023, an estimated $21.1K.
  • Bristol-Myers Squibb made up 0.03% of TIAA FSB's portfolio in Q2 2023, its #180 holding.
  • TIAA FSB first reported a position in Bristol-Myers Squibb in Q2 2017 and has held it in 25 quarters since.
  • TIAA FSB's Bristol-Myers Squibb position peaked at $32M in Q4 2020.
  • 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.